Yes — prescription drugs are one of the ten essential health benefits, so every marketplace plan covers insulin in some form. That word "some" is doing heavy lifting. The questions that decide what you actually pay are which insulins your plan's formulary lists, what tier they sit on, whether the deductible applies before the copay does, and which of your supplies run through the pharmacy versus the equipment benefit.
Every ACA-compliant plan has to cover prescription drugs, and no plan gets to skip insulin as a class. What plans do get to decide is the formulary — the specific list of products they'll pay for, and what tier each one lands on.
In practice that means two people with identical plans from different carriers can take the same daily dose and pay wildly different amounts, because one carrier put their brand on a preferred tier and the other put it a tier up, or listed a different long-acting analog instead. Rapid-acting, long-acting, concentrated, and biosimilar products all get sorted independently. A plan can cover four insulins and still not cover yours.
Three formulary details worth finding before you judge a plan on premium:
One thing I'd rather say plainly: never stretch, ration, or switch insulin products to manage a benefits problem. Which insulin is right for you is a prescriber's call, full stop. Bring the cost problem to them — therapeutic alternatives exist and they know which ones are actually interchangeable for you. My job is to make sure the plan isn't the reason you're in that conversation.
This is the single most common misunderstanding I run into, and it costs people real money at the counter.
The $35-a-month insulin cap comes from the Inflation Reduction Act, and it applies to Medicare — Part D covered insulin, and Part B insulin used in a pump. The version of that provision that would have extended the cap to private and marketplace plans did not survive into the final law. So if you're under 65 on a marketplace plan, that federal cap is not a benefit you have.
Two things partly fill the gap, and both are worth checking by name:
State caps. A number of states have passed their own limits on insulin cost-sharing for state-regulated plans, which generally includes individual marketplace plans sold in that state. The cap amount, whether it's per month or per prescription, and whether it applies before the deductible all vary by state — this is a genuinely state-by-state answer, so ask about yours specifically rather than trusting a national article.
The HDHP pre-deductible allowance. Federal rules now let a high-deductible health plan cover selected insulin products before you've met the deductible without breaking HSA eligibility. Note the verb: plans are allowed to, not required to. If you're on or considering an HSA-eligible plan, ask specifically — it changes the shape of the whole year. And if you're still choosing between plan levels, start with how the metal tiers actually differ: with a predictable monthly drug cost, the lowest premium is very often not the lowest annual spend.
And if you're the one on Medicare, or helping a parent who is, the rules genuinely are different and generally better on this specific point — the 2026 Medicare guide is the right starting place.
Diabetes supplies are covered, but they're split across benefits in a way that catches people out — the same item can be cheap through one door and expensive through the other.
Pharmacy benefit. Test strips, lancets, meters, pen needles, and syringes are commonly filled at the pharmacy, often on a low tier, and sometimes tied to a preferred brand. Plans frequently prefer one strip manufacturer, which means the meter you were handed at diagnosis may not be the one your plan wants to feed.
Durable medical equipment. Insulin pumps and their supplies typically run through the DME benefit, which usually means coinsurance — a percentage — rather than a flat copay, plus prior authorization and an in-network supplier requirement. Continuous glucose monitors are the messy case: depending on the plan, a CGM may be a pharmacy item, a DME item, or available either way at different prices. Ask which route your plan prefers before the first order; people routinely pay the DME price for something their own plan would have filled at the pharmacy counter.
Two more things generally on your side. Diabetes screening for adults in the recommended age and risk range is a covered preventive service, meaning no cost-sharing in network, as is gestational diabetes screening in pregnancy. And many plans cover diabetes self-management education and nutrition counseling — commonly, though not universally, and often with a visit limit. Ask; it's frequently unused because nobody mentions it.
An off-formulary drug isn't the end of the conversation. Marketplace plans are required to have an exceptions process that lets you request coverage of a drug that isn't on the formulary, with your prescriber supporting the request.
The federal framework generally gives the plan up to 72 hours to decide a standard request, and up to 24 hours for an expedited one when your health or your ability to function is at risk. If they say no, you're generally entitled to an external review by an independent reviewer, on a similar clock. And here's the detail almost nobody knows: a drug you obtain through the exceptions process generally has to count toward your annual out-of-pocket maximum, the same as any covered drug.
What makes these requests succeed is documentation, not persistence. The winning version usually shows what else was tried and what happened — prior products, the clinical reason they didn't work or weren't tolerated, and the prescriber's rationale for this specific product. A one-line "patient prefers" gets denied.
Alongside that, one cost route worth knowing. The major insulin manufacturers all run patient assistance and savings programs, and have reduced list prices on several widely used insulins in recent years — check the manufacturer's own site for current terms rather than a coupon aggregator. The catch: some plans operate copay accumulator programs, meaning manufacturer assistance doesn't count toward your deductible or out-of-pocket max. Ask your plan directly whether third-party assistance accrues before you build a year around it.
For most shoppers, the premium is the number that decides it. For an insulin-dependent household, it shouldn't be — the drug line usually moves more money than the premium difference does.
Work it in this order. Pull each plan's formulary and search your exact products by name. Note the tier, the deductible treatment, and any prior authorization. Then check whether your endocrinologist and your preferred pharmacy are in network — pharmacy networks are narrowing, and a mail-order or preferred-pharmacy requirement can change the price of the identical fill. Then run the year: twelve months of insulin and supplies at that plan's cost-sharing, plus premium, against the plan's out-of-pocket maximum. If you're confident you'll hit the maximum, the out-of-pocket max is your annual number, and a richer plan with a lower ceiling frequently wins outright.
Before you rule anything out on price, run the subsidy calculator — cost-sharing reductions attach only to silver plans, and for eligible households they lower the deductible and out-of-pocket max, not just the premium. That's precisely the lever that matters when your spending is predictable and front-loaded. If you want the wider picture of how deductibles, networks, and drug tiers interact, the buyer's guide walks through it without the sales pitch.
Formularies, tiers, and state rules vary by carrier, state, and county, and formularies can change between plan years — so verify against the actual plan documents for the year you're buying before you commit. If you'd like someone to read a formulary with you and check your specific products, that's what I do, and it costs you nothing either way.
Yes. Prescription drugs are one of the ten essential health benefits, so every marketplace plan covers insulin in some form. What varies is which specific insulin products are on the plan's formulary, what tier they sit on, whether the deductible applies first, and whether prior authorization or quantity limits are attached. Check your exact products by name before enrolling.
Generally no. That cap comes from the Inflation Reduction Act and applies to Medicare — Part D covered insulin and Part B insulin used in a pump. The provision that would have extended it to private and marketplace plans didn't make it into the final law. Some states have passed their own insulin cost-sharing caps for state-regulated plans, with the amount and terms varying by state.
Generally yes, but through different benefits. Strips, lancets, meters, and pen needles are commonly pharmacy-benefit items, often on a low tier and sometimes limited to a preferred brand. Pumps and their supplies typically run through durable medical equipment, usually with coinsurance and prior authorization. Continuous glucose monitors may be pharmacy or DME depending on the plan — ask which route yours prefers, because the price can differ substantially.
Request a formulary exception with your prescriber's support. Marketplace plans must have an exceptions process — generally up to 72 hours for a standard decision and 24 hours for an expedited one when your health is at risk — with external review available if it's denied. A drug approved through that process generally counts toward your out-of-pocket maximum. Successful requests document what else was tried and why it didn't work.
Usually yes for commercial and marketplace coverage, though not with Medicare or Medicaid. The catch is copay accumulator programs: some plans don't count manufacturer assistance toward your deductible or out-of-pocket maximum, so the discount helps now but doesn't move you toward your ceiling. Ask your plan directly whether third-party assistance accrues before you build a budget around it.
Screening for prediabetes and type 2 diabetes is a recommended preventive service for adults in the specified age and risk range, and recommended preventive services are generally covered with no cost-sharing when you use an in-network provider. Gestational diabetes screening in pregnancy is similarly covered. Once you're being treated rather than screened, ordinary cost-sharing applies.
Plans differ by carrier, county, and income. I'll check the actual 2026 plans where you live — free, in about 10 minutes, no pressure.
No cost. No pressure. No obligation to enroll.
Free tools and guides — no phone number required:
Important: This article is general information, not insurance, legal, tax, or medical advice. Coverage details vary by plan, carrier, state, and county, and change over time — always confirm benefits with the specific plan documents or a licensed agent before making decisions. Smooth Health Solutions is not connected with or endorsed by the U.S. government, the federal Medicare program, CMS, HealthCare.gov, or any state marketplace or government agency.